What can be done across the health care community to best respond to infectious diseases like Ebola?
Dr. Chin on Ebola
Submitted by Emily on Wed, 10/29/2014 - 10:12
The Ebola outbreak in Western Africa, with multiple cases in the U.S., is of great concern to PhRMA and its members. Patients are at the center of everything we do, and the biopharmaceutical industry is ready to help individuals who have been affected by this devastating disease.
Share
Email
Print
var switchTo5x = false;var __st_loadLate = true;stLight.options({"publisher":"dr-e0d16a36-b72f-d979-d8a1-314a351971a6"});
$('#shareSocial').click(fun...
Source: PHRMA - October 29, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Dr. Chin on Ebola
The Ebola outbreak in Western Africa, with multiple cases in the U.S., is of great concern to PhRMA and its members. Patients are at the center of everything we do, and the biopharmaceutical industry is ready to help individuals who have been affected by this devastating disease.
Biopharmaceutical researchers have been working to develop vaccines and treatments even before the recent outbreak, and as a result there are at least two vaccines for Ebola currently in the pipeline. While it typically takes between 10 and 15 years of research and development and an average of $1.2 billion to bring a drug to market, the World Hea...
Source: PHRMA - October 29, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Leonard Lichtenfeld on T3
YouTube ID: IHFS0ahG6Zg (Source: PHRMA)
Source: PHRMA - October 15, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Newton Crenshaw on T3
YouTube ID: 2nGNBouLuSI (Source: PHRMA)
Source: PHRMA - October 15, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Linda House on T3
YouTube ID: uQwz_ZGpEtk (Source: PHRMA)
Source: PHRMA - October 15, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Stephen Eck on T3
YouTube ID: JjIsAAkIEOE (Source: PHRMA)
Source: PHRMA - October 15, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
PhRMA was excited to participate in the Turning the Tide Against Cancer national conference. Watch participants share their thoughts on scientific advances in cancer treatments.
Newton Crenshaw on T3
Submitted by Emily on Wed, 10/15/2014 - 10:07
Share
Email
Print
var switchTo5x = false;var __st_loadLate = true;stLight.options({"publisher":"dr-e0d16a36-b72f-d979-d8a1-314a351971a6"});
$('#shareSocial').click(function(e) { e.preventDefault(); openSocial(); });
function openSocial() {
$('#shareSocial').toggleClass('active');
$('#social').slideToggle();
}
Sign-up for Updates
Subscribe to RSS
Linda House ...
Source: PHRMA - October 15, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
See What Industry Leaders, Experts, and PhRMA Members Discussed at the Turning the Tide Against Cancer Meeting.
Newton Crenshaw on T3
Submitted by Emily on Wed, 10/15/2014 - 10:07
Share
Email
Print
var switchTo5x = false;var __st_loadLate = true;stLight.options({"publisher":"dr-e0d16a36-b72f-d979-d8a1-314a351971a6"});
$('#shareSocial').click(function(e) { e.preventDefault(); openSocial(); });
function openSocial() {
$('#shareSocial').toggleClass('active');
$('#social').slideToggle();
}
Sign-up for Updates
Subscribe to RSS
Linda House ...
Source: PHRMA - October 15, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Roy Herbst on T3
YouTube ID: 7pYRMFbPl0Q (Source: PHRMA)
Source: PHRMA - October 15, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Leonard Lichtenfeld
M.D., MACP, Deputy Chief Medical OfficerDr. Lichtenfeld currently serves as Deputy Chief Medical Officer for the American Cancer Society in the Society's Office of the Chief Medical Officer located at the Society's Corporate Center in Atlanta.
Dr. Lichtenfeld joined the Society in 2001 as a medical editor, and in 2002 assumed responsibility for managing the Society's then newly created Cancer Control Science Department which included the prevention and early detection of cancer, emerging cancer science and trends, health equity, quality of life for cancer patients, the science of cancer communications and the role of nutri...
Source: PHRMA - October 15, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Newton Crenshaw
Vice President, Lilly Oncology Global Business Development and AdvocacyNewton F. Crenshaw became Vice President - Lilly Oncology Global Business Development and Advocacy for Eli Lilly and Company (Lilly) in July, 2011. He had previously served as Global business-to-payer, bio-medicines & corporate affairs and Crenshaw is a member of the company’s senior management council.
He received a Bachelor of Arts degree with honors in economics from DePauw University in 1985, where he was named a Management Fellow in the university’s honors program in the Center of Management and Entrepreneurship.
Crenshaw joined Lilly in 19...
Source: PHRMA - October 15, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Linda House
Executive Vice President of External AffairsLinda House joined the Cancer Support Community in February 2012 as Executive Vice President of External Affairs where she oversees the development, communications, and public policy efforts of the national organization. Linda joined CSC with around 30 years of experience working in the cancer care environment, 17 years being direct patient care in the acute and hospice care setting.
Immediately prior to joining CSC, Linda served as Executive Director of St. Vincent Cancer Care in Indianapolis where she led a team of individuals to provide care across the cancer continuum. Pr...
Source: PHRMA - October 15, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Stephen Eck
M.D., Ph.D.,Vice President and Global Head of OncologyStephen Eck, M.D., Ph.D, is Vice President and Global Head of Oncology Medical Sciences at Astellas Pharma Global Development (Headquartered in Northbrook, IL). He is directly responsible for the oversight of oncology drug development plans. Much of this work is focused on special cancer populations for which unique biology enables the development of personalized cancer therapies. Dr. Eck previously served as Vice President, Translational Medicine & Pharmacogenomics at Eli Lilly and Company (2007-2011) where he was responsible for the clinical pharmacology component...
Source: PHRMA - October 15, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Men's Health Network on National Survey
The Second Annual National Health Survey by PhRMA provides some valuable insights into what people are thinking – and doing – about their health. One of the key findings is that over half of Americans, including 55% of men, are paying more attention to their health than they were a few years ago. This is an encouraging trend that reflects greater general health awareness in recent years.
There are many factors that may be contributing to this increasing awareness, particularly among men. First, large public health campaigns such as Men's Health Month in June, celebrated across the country, have highlighted the ...
Source: PHRMA - September 26, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Brandon Leonard
Director of Strategic InitiativesMen's Health Network (MHN) is a national non-profit organization whose mission is to reach men, boys, and their families where they live, work, play, and pray with health awareness messages and tools, screening programs, educational materials, advocacy opportunities, and patient navigation. For more information, please visit www.menshealthnetwork.org.
menshealthnetworkmenshealthnetworkCompany: Men's Health Network (Source: PHRMA)
Source: PHRMA - September 26, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
